Sep 07, 2023 / 05:50PM GMT
David Neil Lebowitz - Citigroup Inc., Research Division - Research Analyst
David Lebowitz. I am one of the biotech analysts here at Citi. And thank you for attending the Citi 18th Annual Biopharma Conference. Happy to have on stage with me from Ionis from warm San Diego. Oh, it's pretty warm here today as well, actually. I guess if you could start by introducing yourselves and then maybe walk through the top-level mission of Ionis and the technology behind that mission.
Elizabeth L. Hougen - Ionis Pharmaceuticals, Inc. - Executive VP of Finance & CFO
Sure. Happy to. Thank you for having us, David. I'm Beth Hougen, Ionis' Chief Financial Officer, and I've been with the company now for over 23 years. So I'm looking forward to talking a bit more about Ionis today because we really are in the midst of an important transformation for the company.
D. Wade Walke - Ionis Pharmaceuticals, Inc. - SVP of IR
And I'm Wade Walke, I'm the Head of Investor Relations.
Ionis Pharmaceuticals Inc at Citi BioPharma Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot